Goldport Capital

Total investments

44

Average round size

17M

Portfolio companies

38

Rounds per year

4.40

Lead investments

14

Follow on index

0.14

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareArtificial IntelligenceHealth CareManufacturingMedical DeviceMedicalEventsSemiconductorBiopharma

Summary

Goldport Capital is the famous VC, which was founded in 2014. The leading representative office of defined VC is situated in the Shenzhen. The company was established in Asia in China.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2018. Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

The current fund was established by Houbo Cheng, Xiongwei Wu, Yuelong Zhu.

Among the most popular portfolio startups of the fund, we may highlight Microtech Medical, Gowild. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Events, Information Technology. The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Goldport Capital, startups are often financed by Shenzhen Nalande Investment Fund, Qiming Venture Partners, Lilly Asia Ventures. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Juren Capital, China Merger & Acquisition Fund. In the next rounds fund is usually obtained by Qianhai Yuzhou Fund, Famous City Development Venture Capital, Ecovacs.

Show more

Investments analytics

Analytics

Total investments
44
Lead investments
14
Rounds per year
4.40
Follow on index
0.14
Investments by industry
  • Manufacturing (13)
  • Medical (13)
  • Biotechnology (8)
  • Biopharma (8)
  • Health Care (6)
  • Show 49 more
Investments by region
  • China (43)
Peak activity year
2023
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
113M
Group Appearance index
0.70
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ruigu New Materials 24 May 2024 Seed 15M Zhejiang, Quzhou, China
Xingchenhai 20 Sep 2023 Manufacturing, Drones Early Stage Venture Hangzhou, Zhejiang, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.